Altasciences has signed a definitive agreement to acquire the preclinical testing business of SNBL U.S.A. The transaction is expected to be completed at the end of September.  This acquisition will add comprehensive preclinical safety testing services to Altasciences’ current full-service clinical and bioanalytical offerings. Altasciences will now support all crucial steps in early-stage drug development, from lead candidate selection to proof of concept.  “Expanding our services to incl...